Ellington Management Group’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-22,536
Closed -$816K 199
2021
Q1
$816K Buy
+22,536
New +$800K 0.1% 80
2020
Q2
Sell
-20,764
Closed -$643K 325
2020
Q1
$643K Buy
+20,764
New +$708K 0.15% 187
2019
Q2
Sell
-15,599
Closed -$629K 724
2019
Q1
$629K Buy
+15,599
New +$625K 0.11% 195
2018
Q1
Sell
-38,682
Closed -$1.33M 977
2017
Q4
$1.33M Buy
+38,682
New +$1.32M 0.22% 58
2014
Q3
Sell
-27,404
Closed -$772K 434
2014
Q2
$772K Buy
27,404
+20,131
+277% +$574K 0.36% 30
2014
Q1
$222K Sell
7,273
-5,586
-43% -$167K 0.07% 489
2013
Q4
$374K Buy
+12,859
New +$374K 0.13% 252

Other funds holding PFE

Ellington Management Group's PFE Position: Q2 2021 in Review

Ellington Management Group sold out of Pfizer (PFE) in Q2 2021, closing a stake of 22,536 shares — an estimated $816K sold.

Ellington Management Group first reported a position in PFE in Q4 2013 and held it in 7 quarters. The position peaked at $1.33M in Q4 2017. 2,732 funds tracked by Wall St. Rank hold PFE as of Q2 2021.

  • Ellington Management Group reported no remaining Pfizer position as of Q2 2021 after selling out during the quarter.
  • Ellington Management Group sold 22,536 Pfizer shares in Q2 2021, an estimated $816K.
  • Ellington Management Group first reported a position in Pfizer in Q4 2013 and held it in 7 quarters.
  • Ellington Management Group's Pfizer position peaked at $1.33M in Q4 2017.
  • 2,732 funds tracked by Wall St. Rank held Pfizer as of Q2 2021.

Based on Ellington Management Group's 13F filing for Q2 2021, filed 16 Aug 2021.